Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Differentiated Thyroid Cancer × apatinib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Adrenocortical Carcinoma 2 Radioactive Iodine-refractory Differentiated Thyroid Cancer 1 Neuroendocrine Tumors 1 Differentiated Thyroid Cancer 1 Adrenal Gland Neoplasms 1

Interventions

Thyrotropin Alfa 3 donafenib 2 Injections 2 surufatinib 1 pembrolizumab 1 lenvatinib 1 apatinib 1 anlotinib 1 Sorafenib 1 Iodine-131 1 Everolimus 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03048877 2023-04-12

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Peking Union Medical College Hospital

Phase 3 Unknown

EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡